Primary Country (Mandatory)

Other Country (Optional)

Set News Language for United States

Primary Language (Mandatory)
Other Language[s] (Optional)
No other language available

Set News Language for World

Primary Language (Mandatory)
Other Language(s) (Optional)

Set News Source for United States

Primary Source (Mandatory)
Other Source[s] (Optional)

Set News Source for World

Primary Source (Mandatory)
Other Source(s) (Optional)
  • Countries
    • India
    • United States
    • Qatar
    • Germany
    • China
    • Canada
    • Singapore
    • World
  • Categories
    • National
    • International
    • Business
    • Entertainment
    • Sports
    • Special
    • All Categories
  • Available Languages for United States
    • English
  • All Languages
    • English
    • Hindi
    • Arabic
    • German
    • Chinese
    • French
  • Sources
    • India
      • AajTak
      • NDTV India
      • The Hindu
      • India Today
      • Zee News
      • NDTV
      • BBC
      • The Wire
      • News18
      • News 24
      • The Quint
      • ABP News
      • Zee News
      • News 24
    • United States
      • CNN
      • Fox News
      • Al Jazeera
      • CBSN
      • NY Post
      • Voice of America
      • The New York Times
      • HuffPost
      • ABC News
      • Newsy
      • USA TODAY
      • NBC News
      • CNBC
    • Qatar
      • Al Jazeera
      • Al Arab
      • The Peninsula
      • Gulf Times
      • Al Sharq
      • Qatar Tribune
      • Al Raya
      • Lusail
    • Germany
      • DW
      • ZDF
      • ProSieben
      • RTL
      • n-tv
      • Die Welt
      • Süddeutsche Zeitung
      • Frankfurter Rundschau
    • China
      • China Daily
      • BBC
      • The New York Times
      • Voice of America
      • Beijing Daily
      • The Epoch Times
      • Ta Kung Pao
      • Xinmin Evening News
    • Canada
      • CBC
      • Radio-Canada
      • CTV
      • TVA Nouvelles
      • Le Journal de Montréal
      • Global News
      • BNN Bloomberg
      • Métro
    • Singapore
      • CNA
      • The Straits Times
      • Lianhe Zaobao
‘Greed, greed, greed’: Sanders demands Ozempic maker lower prices

‘Greed, greed, greed’: Sanders demands Ozempic maker lower prices

CNN
Wednesday, September 25, 2024 02:04:31 PM UTC

While grilling Novo Nordisk’s chief executive over the price of its blockbuster diabetes and weight-loss drugs, Ozempic and Wegovy, on Tuesday, Sen. Bernie Sanders alleged that 40,000 people a year in the US could die if the company doesn’t make the medicines more affordable.

While grilling Novo Nordisk’s chief executive over the price of its blockbuster diabetes and weight-loss drugs, Ozempic and Wegovy, on Tuesday, Sen. Bernie Sanders alleged that 40,000 people a year in the US could die if the company doesn’t make the medicines more affordable. “From a moral perspective, does it bother you knowing that keeping the price of Ozempic and Wegovy so high in the United States could lead to the preventable deaths of tens of thousands of Americans?” Sanders, chairman of the US Senate Health, Education, Labor and Pensions Committee, asked the Danish drugmaker’s CEO, Lars Fruergaard Jorgensen, citing research from a Yale epidemiologist. “We are very committed to making sure that Americans have access at an affordable price point for our medicines,” Jorgensen replied. “There’s no thing we would rather see happen.” It was the latest in a series of hearings Sanders has led with pharmaceutical company CEOs about the price of medicines in the US, which are higher – often by multiple times – than in other wealthy countries. But perhaps no drugs have garnered more attention than Novo Nordisk’s Ozempic, approved for diabetes, and its sister drug, Wegovy, for weight loss and reduction of heart risk. The medicines, also referred to as GLP-1s for the hormone they mimic, are now used by millions of Americans but are still unaffordable and out of reach for many. Sanders, who launched an investigation of Novo Nordisk in April over what he called “outrageously high prices” for the medications in the US, has focused on the drugs’ comparative cost in other countries: He noted that the list price for a four-week supply of Ozempic is $969 in America, but the drug can be purchased for $155 in Canada, $122 in Denmark and $59 in Germany. Similarly, Wegovy’s list price is $1,349 in the US, but it costs $186 in Denmark, $140 in Germany and $92 in the United Kingdom, he said. Tuesday’s hearing boiled down to a familiar argument over who is responsible for the US’s higher prices: drug companies that set starting – or “list” – prices or pharmacy benefit managers, the middlemen that negotiate discounts on those list prices in exchange for favorable insurance coverage and access.

Read full story on CNN
Share this story on:-
More Related News
‘X-Files’ stars, Chloe Sevigny and Janet Jackson tunes: Fashion goes full ’90s

At Paris Fashion Week, there were luxuriously plain black dresses and coats of the kind favored by Carolyn Bessette Kennedy, models strutting down runways with theatrical flourishes, and in some cases, no cellphones in sight.

Millions of Americans are skipping meals or cutting back on utilities to afford health care

Roughly one-third of respondents – equivalent to more than 82 million Americans – said they have had to cut back on at least one daily living expense to cover their health care bills, according to a new survey.

South Africa’s extravagant matric balls are the ‘Met Gala’ of high school dances

Before South African high school students complete their final exams, they first walk the red carpet, pulling out all the stops for their celebratory matriculation, or ‘matric,’ balls. The photographer Alice Mann documented the increasingly lavish dances for five years in her new book, “The Night is Young.”

‘Betrayed’: Families are dealing with dashed hopes after pivot on autism treatment

The drug leucovorin was touted by the Trump administration in September as a potential treatment for thousands of children with autism. Now, some parents and guardians of children with autism say they feel abandoned by the US Food and Drug Administration’s new stance on leucovorin.

FDA declines to endorse leucovorin for autism, walking back earlier statements suggesting benefit

The prescription drug leucovorin is getting a label update, though it’s not what that the US Food and Drug Administration suggested might be coming during a White House briefing in September, when officials touted the drug as a potential treatment for thousands of children with autism.

Maggie Gyllenhaal and Jessie Buckley reimagine Frankenstein’s bride

With the release of “The Bride!” we asked scholars, film curators and experts in Mary Shelley’s work why so few women have tackled the Frankenstein story — and the impact that has on how we make sense of the 200-year-old tale.

Look of the Week: In an ethereal gown, Eileen Gu gets her wings

In front of the Louvre Pyramid, Eileen Gu stepped out this week wearing a set of diaphanous wings — a fitting ensemble for an Olympic athlete whose sport sends her airborne.

Leucovorin prescriptions surged after the White House touted the drug for autism. Parents are still scrambling to find it

Meagan Johnson recently spent four days calling dozens of pharmacies around Austin, Texas, trying to fill a prescription for her son, Jack.

Could popular weight loss drugs become the new treatment for addiction? Evidence is starting to mount

Evidence is mounting that the wildly popular weight-loss medicines known as GLP-1s may also hold potential for treating addiction, and the field may be on the verge of obtaining desperately needed answers through more study.

Why England soccer star Chloe Kelly gets her own Barbie doll

Known for her blistering pace and powerful shots, the soccer player is having a Barbie made in her likeness as the toymaker names her as role model of the year.

The most striking looks from the Actor Awards red carpet

The Screen Actors Guild Awards are back with a new name — and a thematic dress code.

The task force that shapes Americans’ preventive care has not met in a year. Doctors now worry it’s being ‘abandoned’ by HHS

There’s growing concern that the US Department of Health and Human Services is abandoning the US Preventive Services Task Force – or pushing it into “quiet paralysis.”

Meeting to determine US measles elimination status pushed back to November

An international meeting to determine the status of measles elimination in the United States has been delayed seven months, from its original date in mid-April until sometime in November.

The push to end animal testing is gaining steam, but technology can’t fill the gap yet

The FDA has released draft guidance that aims to clear up how drug developers can use alternative testing – but that doesn’t mean animal testing in the US is over.

The push to end animal testing is gaining steam, but technology can’t fill the gap yet

The FDA has released draft guidance that aims to clear up how drug developers can use alternative testing – but that doesn’t mean animal testing in the US is over.

‘She’s a real Scorpio’: Gen Z’s love for astrology is showing up in their jewelry

What is your moon sign? And your sun? These are not, it seems, trivial questions for Gen Z, who are fueling demand for zodiac-themed jewelry designs.

He spent $69 million on an NFT. Five years on, he believes in digital art more than ever

It was the third-highest sum ever paid at auction for the work of a living artist. But following the NFT market’s spectacular collapse, is Vignesh Sundaresan’s record purchase worth anything at all?

Weight-loss treatment is on the verge of a dramatic shift – again

About 10 weeks after it was approved, the Wegovy pill is now estimated to be part of the daily regimen of about 400,000 Americans. And the field of weight-loss treatment is on the verge of even more head-spinning change.

Heart benefits fade after stopping GLP-1 medications

One major benefit of taking injected GLP-1 medications is a sizeable reduction in risk for heart attacks, strokes and other heart problems.

Heart benefits fade after stopping GLP-1 medications

One major benefit of taking injected GLP-1 medications is a sizeable reduction in risk for heart attacks, strokes and other heart problems.

He spent $69 million on an NFT. Five years on, he believes in digital art more than ever

It was the third-highest sum ever paid at auction for the work of a living artist. But following the NFT market’s spectacular collapse, is Vignesh Sundaresan’s record purchase worth anything at all?

At the Oscars after-party, stars slip into something more sensual

Once the Academy Awards wrapped up on Sunday evening, stars poured into the Los Angeles County Museum of Art for the Vanity Fair after-party, several changing into clothes that were sexy, strange and practically R-rated.

US judge blocks Kennedy’s efforts to overhaul US vaccine policy

A federal judge on Monday blocked some of the sweeping changes US Health and Human Services Secretary Robert F. Kennedy made to reshape US vaccine policy, including an effort to shrink the number of vaccines recommended for children.

Look of the Week: Harry Styles proves that ‘It-bags’ are for the boys, too

With his maxi leopard print Chanel bag, the pop star issued a loud and proud proclamation that he got his hands on one of the most in-demand, status-bestowing styles of the moment.

Millions more people may need to start cholesterol-lowering medications as young as their 30s. Here’s why

Millions more adults should consider starting cholesterol-lowering medications earlier to reduce their risk of heart attack and stroke, according to new medical guidance.

© 2008 - 2026 Webjosh  |  News Archive  |  Privacy Policy  |  Contact Us